(A) A qualified entity may acquire and maintain a supply of epinephrine autoinjectors pursuant to either of the following:

(1) The autoinjectors are personally furnished by a prescriber, or obtained pursuant to a prescription issued by a prescriber, in accordance with section 4723.483, 4730.433, or 4731.96 of the Revised Code.

(2) The autoinjectors are dispensed by a pharmacist or pharmacy intern in accordance with a protocol as authorized under section 4729.47 of the Revised Code.

(B) Epinephrine autoinjectors acquired pursuant to this section shall be stored in a location readily accessible in an emergency and maintained in accordance with the manufacturer's instructions and any additional requirements that may be established by the department of health under section 3728.11 of the Revised Code.

(C) A qualified entity that acquires epinephrine autoinjectors pursuant to this section shall designate one or more individuals who are employees or agents of the entity and have successfully completed anaphylaxis training in accordance with section 3728.04 of the Revised Code to be responsible for oversight of the epinephrine autoinjectors, including storage, maintenance, and control. The qualified entity may authorize those individuals and other individuals who have successfully completed the anaphylaxis training to administer epinephrine.

Amended by 132nd General Assembly File No. TBD, HB 101, §1, eff. 4/8/2019.

Added by 131st General Assembly File No. TBD, HB 200, §1, eff. 9/8/2016.

Related Legislative Provision: See 132nd General Assembly File No. TBD, HB 101, §3.